
Quarterly report 2025-Q3
added 10-24-2025
The Procter & Gamble Company Revenue 2011-2025 | PG
Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.
Traditionally defined as follows:Revenue = Price * Quantity of productsRevenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.[1]
This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.
Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.
Annual Revenue The Procter & Gamble Company
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 84.3 B | 84 B | 82 B | 80.2 B | 76.1 B | 71 B | 67.7 B | 66.8 B | 65.1 B | 65.3 B | 76.3 B | 83.1 B | 84.2 B | 83.7 B | 82.6 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 84.3 B | 65.1 B | 76.8 B |
Quarterly Revenue The Procter & Gamble Company
| 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 22.4 B | 19.8 B | 21.9 B | 21.7 B | 20.2 B | 21.4 B | 21.9 B | 20.1 B | 20.8 B | 20.6 B | 41.4 B | 19.4 B | 21 B | 20.3 B | 41.3 B | 18.1 B | 19.7 B | 19.3 B | 19.7 B | 19.3 B | 18.2 B | 17.8 B | 18.2 B | 17.8 B | 17.4 B | 16.7 B | 16.5 B | 16.3 B | 17.4 B | 16.7 B | 17.4 B | 16.7 B | 16.9 B | 16.5 B | 16.9 B | 16.5 B | 16.9 B | 16.5 B | 16.9 B | 16.5 B | 18.5 B | 18.8 B | 20.2 B | 20.8 B | 19.3 B | 18.8 B | 22.3 B | 21.2 B | 21.7 B | 20.3 B | 22.2 B | 20.7 B | 21.7 B | 21.5 B | 22.1 B | 21.9 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 41.4 B | 16.3 B | 20.1 B |
References
- Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).
Revenue of other stocks in the Household products industry
| Issuer | Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Natura &Co Holding S.A.
NTCO
|
26.7 B | - | - | $ 9.02 B | - | |
|
Colgate-Palmolive Company
CL
|
20.1 B | $ 78.29 | 1.35 % | $ 64.1 B | ||
|
The Clorox Company
CLX
|
7.1 B | $ 103.89 | 1.03 % | $ 12.8 B | ||
|
Dogness (International) Corporation
DOGZ
|
27.1 M | $ 10.64 | -2.35 % | $ 359 M | ||
|
Coty
COTY
|
5.89 B | $ 3.22 | -3.59 % | $ 2.8 B | ||
|
LifeVantage Corporation
LFVN
|
229 M | $ 6.51 | -0.15 % | $ 79.8 M | ||
|
Acme United Corporation
ACU
|
194 M | $ 40.13 | 3.24 % | $ 149 M | ||
|
The Estée Lauder Companies
EL
|
14.3 B | $ 104.12 | -1.36 % | $ 37.5 B | ||
|
e.l.f. Beauty
ELF
|
321 M | $ 76.44 | -1.98 % | $ 4.18 B | ||
|
Nature's Sunshine Products
NATR
|
445 M | $ 22.7 | 2.39 % | $ 433 M | ||
|
Church & Dwight Co.
CHD
|
6.11 B | $ 84.59 | 1.22 % | $ 20.7 B | ||
|
Kimberly-Clark Corporation
KMB
|
20.1 B | $ 103.21 | -0.23 % | $ 34.6 B | ||
|
Nu Skin Enterprises
NUS
|
1.73 B | $ 10.63 | 1.43 % | $ 528 M | ||
|
Revlon
REV
|
2.08 B | - | -4.41 % | $ 212 M | ||
|
Helen of Troy Limited
HELE
|
1.91 B | $ 21.1 | -3.92 % | $ 486 M | ||
|
Hims & Hers Health
HIMS
|
1.48 B | $ 37.08 | -1.83 % | $ 8.01 B | ||
|
Edgewell Personal Care Company
EPC
|
2.25 B | $ 17.49 | -0.14 % | $ 869 M | ||
|
Inter Parfums
IPAR
|
1.32 B | $ 84.22 | 1.7 % | $ 2.69 B | ||
|
Spectrum Brands Holdings
SPB
|
2.81 B | $ 61.19 | -1.7 % | $ 1.57 B | ||
|
United-Guardian
UG
|
10.9 M | $ 6.0 | -0.01 % | $ 27.6 M | ||
|
Mannatech, Incorporated
MTEX
|
132 M | $ 8.65 | -2.15 % | $ 16.1 M | ||
|
Newell Brands
NWL
|
7.58 B | $ 3.81 | -1.68 % | $ 1.58 B | ||
|
USANA Health Sciences
USNA
|
921 M | $ 20.47 | -0.1 % | $ 394 M | ||
|
Unilever PLC
UL
|
60.8 B | $ 64.84 | 0.03 % | $ 132 B |